| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.094 | 0.01 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.01 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | 0.35 | 0.01 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.02 |